[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Bedaya Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":114},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,46,68,87],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100636717","phase-2-successive-doses-of-gnrh-agonist-versus-single-dose-of-gnrh-agonist-to-trigger-ovulation-in-hyper-responders-100636717",false,"NCT07569315","Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders","Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders Undergoing IVF Cycle : A Randomized Controlled Study.","Inclusion Criteria:\n\n* GnRH antagonist IVF cycle\n* Hyper-responders to induction of ovulation\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion","FEMALE","18 Years","40 Years",{"count":20,"type":21},190,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders",[27],"Infertility",[27,29,30,31,32],"GnRH agonist trigger","IVF-ET","Hyper-responders","PCOS","NOT_YET_RECRUITING","2026-05-06",{"date":36,"type":37},"2026-05-11","ACTUAL",{"date":39,"type":21},"2026-06-01",{"date":41,"type":21},"2028-04-01",{"name":43,"class":44},"Bedaya Hospital","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":65,"completionDateStruct":66,"leadSponsor":67,"locationsCount":45},"100636715","phase-2-triggering-oocyte-maturation-in-poseidon-group-3-and-4-poor-responders-using-double-trigger-or-hcg-trigger-100636715","NCT07569289","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger . A Randomized Controlled Study","Inclusion Criteria:\n\n* POSEIDON group 3 and 4\n* GnRH antagonist IVF cycle\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion",{"count":54,"type":21},164,[24],"The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \\[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \\] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation",[27],[27,59,30,60,61,62],"Poor responders","HCG","GnRH agonist","Double trigger","2026-04-29",{"date":34,"type":37},{"date":39,"type":21},{"date":41,"type":21},{"name":43,"class":44},{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":4,"eligibilityCriteria":74,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":75,"targetDuration":4,"studyType":22,"phases":77,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":83,"startDateStruct":84,"completionDateStruct":85,"leadSponsor":86,"locationsCount":45},"100636716","phase-2-triggering-ovulation-in-normo-responders-using-a-modified-dual-trigger-protocol-or-hcg-trigger-100636716","NCT07569302","Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger","Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger . A Randomized Controlled Study","Inclusion Criteria:\n\n* GnRH antagonist IVF cycle\n* Normo-responders to induction of ovulation\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion",{"count":76,"type":21},196,[24],"The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \\[a single bolos of HCG combined with two successive doses of a GnRH agonist \\] with HCG \\[a single bolos administered 36 hours before oocyte retrieval \\] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.",[80],"Infertility (IVF Patients)",[27,30,82,61,60],"Normo-responders",{"date":34,"type":37},{"date":39,"type":21},{"date":41,"type":21},{"name":43,"class":44},{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":4,"eligibilityCriteria":93,"healthyVolunteers":11,"sex":16,"minAge":94,"maxAge":95,"enrollmentInfo":96,"targetDuration":4,"studyType":22,"phases":98,"briefSummary":99,"conditions":100,"keywords":101,"overallStatus":104,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},"100532384","phase-2-dydrogesterone-versus-gnrh-antagonist-in-poor-responders-undergoing-double-ovarian-stimulation-100532384","NCT06212102","Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation","Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation: A Randomized Controlled Non-inferiority Trial","Inclusion Criteria:\n\nPatients belonging to Poseidon group 4\n\nExclusion Criteria:\n\n* PCOS\n* Endometriosis\n* History of recurrent abortion","35 Years","44 Years",{"count":97,"type":21},120,[24],"The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.",[27],[27,30,102,103],"Poor ovarian responders","Double stimulation","RECRUITING","2026-04-28",{"date":107,"type":37},"2026-05-04",{"date":109,"type":37},"2024-05-08",{"date":111,"type":21},"2027-08-01",{"name":43,"class":44},2,""]